ExploreWatchlistsPricing
  1. JP-listed companies
  2. GNI Group Ltd.
  3. Financials
  4. Pretax margin (%)

GNI Group Ltd. (2160)

Market cap
¥174.3B
P/E ratio
GNI Group develops and manufactures pharmaceuticals and medical devices, serving global markets with key products like Aisuryui in China and biomaterials in the US.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Dec 31, 2025-17.3-1811.54%
Dec 31, 20241-97.92%
Dec 31, 202348.5+999.98%
Dec 31, 20224.4-49.46%
Dec 31, 20218.7-52.79%
Dec 31, 202018.5+14.89%
Dec 31, 201916.1+121.32%
Dec 31, 20187.3+40.34%
Dec 31, 20175.2-117.56%
Dec 31, 2016-29.5-55.23%
Dec 31, 2015-65.9+9.38%
Dec 31, 2014-60.2-85.85%
Dec 31, 2013-425.7+42.25%
Dec 31, 2012-299.2-41.73%
Dec 31, 2011-513.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat